InsidersTradesSigma
Explore the detailed record of transactions filed by 홍성상, 首席执行官. Officer active across 2 companies, notably 경보제약. In total, 7 filings have been logged. History available since 5 March 2026. The latest transaction was disclosed on 17 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Hong Sung-Sang is the Managing Director of 경보제약, a pharmaceutical company. In this role, he oversees operations and research projects, contributing to the innovation and growth of the company. His expertise is essential for the success of strategic initiatives.